Global Large Volume Wearable Injectors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Large Volume Wearable Injectors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

According to our (Global Info Research) latest study, the global Large Volume Wearable Injectors market size was valued at US$ 2062 million in 2023 and is forecast to a readjusted size of USD 14590 million by 2030 with a CAGR of 32.6% during review period.

The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.

This report is a detailed and comprehensive analysis for global Large Volume Wearable Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Large Volume Wearable Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Large Volume Wearable Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Large Volume Wearable Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Large Volume Wearable Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Large Volume Wearable Injectors

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Large Volume Wearable Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, scPharmaceuticals, SteadyMed Therapeutics, Johnson & Johnson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Large Volume Wearable Injectors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Electronical Injectors
Mechanical Injectors
Others

Market segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others

Major players covered
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Large Volume Wearable Injectors product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Large Volume Wearable Injectors, with price, sales quantity, revenue, and global market share of Large Volume Wearable Injectors from 2019 to 2024.

Chapter 3, the Large Volume Wearable Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Large Volume Wearable Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Large Volume Wearable Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Large Volume Wearable Injectors.

Chapter 14 and 15, to describe Large Volume Wearable Injectors sales channel, distributors, customers, research findings and conclusion.